echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > JPR: Analysis of the metabolic properties of the body in PATIENT COVID-19 patients may reveal its multi-organ effects.

    JPR: Analysis of the metabolic properties of the body in PATIENT COVID-19 patients may reveal its multi-organ effects.

    • Last Update: 2020-09-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    September 14, 2020 // -- SARS-CoV-2, which induces COVID-19, causes a range of body symptoms, including respiratory stress, multiple organ failure and even death, and the virus mainly targets the lungs, but many patients also develop symptoms of the non-respiratory system; In the study, published in the international journal Journal of Proteome Research, scientists from The University of Modok and others compared levels of lipoproteins and metabolites in the blood of patients with COVID-19 and healthy individuals, revealing signs of multiple organ damage in patients, or promising to help diagnose and treat COVID-19 patients later.
    Photo Source: NIAID's current diagnosis of COVID-19 relies heavily on the detection of viral RNA and the body's resistance to viral antibodies, both of which are prone to false negative results and other limitations; 2 The method of infection mainly includes analyzing metabolic changes in the body in the later stages of viral infection, in which the researchers wanted to analyze the systemic systemic effects of COVID-19 on patients and determine whether there were general metabolic characteristics of COVID-19 infection.
    researchers studied 17 patients who tested positive for COVID-19 using current methods, 25 healthy control individuals with age, gender and BMI matching them (COVID-19 test results were negative), and then analyzed blood samples from participants' bodies, and then measured the levels of lipoproteins, metabolites, and amino acids in these blood samples using MRI spectroscopy and liquid chromatography-mass spectrometry.
    By using multivariate statistical analysis to detect differences between patients and control individuals, the researchers found metabolic characteristics of SARS-CoV-2 infections, including acute inflammation, liver damage, diabetes and cardiovascular disease risk, and are now looking at larger patients In addition to using metabolite-based diagnostic testing techniques developed, the researchers said, the results suggest that COVID-19 rehabilitation should be evaluated to determine whether their risk of other diseases increases.
    () Original source: Ruey Leng Loo, Samantha Lodge, Torben Kimhofer, et al. Quantitative In-Vitro Diagnostic NMR Spectroscopy for Lipoprotein and Metabolite Measurements in Plasma and Serum: Recommendations for Analytic Artefact Basication with Special Reference to COVID-19/SARS-CoV-2 Samples, Journal of Proteome Research (2020). DOI: 10.1021/acs.jproteome.0c00537.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.